Noble Financial Starts Evoke Pharma (EVOK) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Brean Capital Reiterates Buy After Evoke Pharma (EVOK) Extends Interest-Payment-Only Period
October 7, 2015 11:52 AM EDTBrean Capital reiterated a Buy rating and $13.00 price target on Evoke Pharma (NASDAQ: EVOK) after negotiating for its interest-payment-only period to be extended for another year. The deal reduces Evokes debt payments by $2.2 million in the next year by eliminating principal payments and... More
